1. Home
  2. BUJA vs PETS Comparison

BUJA vs PETS Comparison

Compare BUJA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BUJA
  • PETS
  • Stock Information
  • Founded
  • BUJA 2022
  • PETS 1996
  • Country
  • BUJA Malaysia
  • PETS United States
  • Employees
  • BUJA N/A
  • PETS N/A
  • Industry
  • BUJA Blank Checks
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • BUJA Finance
  • PETS Consumer Staples
  • Exchange
  • BUJA Nasdaq
  • PETS Nasdaq
  • Market Cap
  • BUJA N/A
  • PETS 82.0M
  • IPO Year
  • BUJA 2023
  • PETS N/A
  • Fundamental
  • Price
  • BUJA $10.96
  • PETS $4.07
  • Analyst Decision
  • BUJA
  • PETS Sell
  • Analyst Count
  • BUJA 0
  • PETS 2
  • Target Price
  • BUJA N/A
  • PETS $3.50
  • AVG Volume (30 Days)
  • BUJA 2.7K
  • PETS 182.6K
  • Earning Date
  • BUJA 01-01-0001
  • PETS 11-06-2024
  • Dividend Yield
  • BUJA N/A
  • PETS 29.41%
  • EPS Growth
  • BUJA N/A
  • PETS N/A
  • EPS
  • BUJA 0.29
  • PETS N/A
  • Revenue
  • BUJA N/A
  • PETS $270,772,000.00
  • Revenue This Year
  • BUJA N/A
  • PETS N/A
  • Revenue Next Year
  • BUJA N/A
  • PETS $3.27
  • P/E Ratio
  • BUJA $37.13
  • PETS N/A
  • Revenue Growth
  • BUJA N/A
  • PETS 2.26
  • 52 Week Low
  • BUJA $10.30
  • PETS $2.90
  • 52 Week High
  • BUJA $12.18
  • PETS $8.27
  • Technical
  • Relative Strength Index (RSI)
  • BUJA 67.66
  • PETS 56.76
  • Support Level
  • BUJA $10.85
  • PETS $3.78
  • Resistance Level
  • BUJA $10.85
  • PETS $4.17
  • Average True Range (ATR)
  • BUJA 0.00
  • PETS 0.18
  • MACD
  • BUJA -0.00
  • PETS -0.01
  • Stochastic Oscillator
  • BUJA 87.50
  • PETS 62.22

About BUJA Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd is a blank check company.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: